Compounds > phenelzine
Page last updated: 2024-10-28

phenelzine and Diabetes Mellitus, Type 1

phenelzine has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albareda, M1
Udina, C1
Escartín, A1
Corcoy, R1

Other Studies

1 other study available for phenelzine and Diabetes Mellitus, Type 1

ArticleYear
Seizures in a diabetic patient on monoamine oxidase inhibitors.
    The American journal of emergency medicine, 1999, Volume: 17, Issue:1

    Topics: Adult; Antidepressive Agents; Depressive Disorder; Diabetes Mellitus, Type 1; Epilepsy, Tonic-Clonic

1999